Product Images Alyftrek

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Alyftrek NDC 51167-135 by Vertex Pharmaceuticals Incorporated, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - alyftrek 01

Chemical Structure - alyftrek 01

Chemical Structure - alyftrek 02

Chemical Structure - alyftrek 02

Chemical Structure - alyftrek 03

Chemical Structure - alyftrek 03

PRINCIPAL DISPLAY PANEL - 4 mg/20 mg/50 mg Blister Pack Carton - alyftrek 04

PRINCIPAL DISPLAY PANEL - 4 mg/20 mg/50 mg Blister Pack Carton - alyftrek 04

alyftrek™ is a medication available in tablet form, containing vanzacaftor, tezacaftor, and deutivacaftor in varying doses of 4mg, 20mg, or 50mg per tablet. It is recommended to take the medication as directed by your pharmacist and to ensure that each dose is taken at the same time daily. It is important to consult with your pharmacy to ensure timely supply of the medication. The tablets should be stored at room temperature between 68°F (20°C) to 77°F (25°C), with excursions permitted from 59°F to 86°F (15°C to 30°C). Remember to keep the medication out of sight and reach of children. Additionally, each patient should be provided with a Medication Guide by the pharmacist.*

PRINCIPAL DISPLAY PANEL - 10 mg/50 mg/125 mg Blister Pack Carton - alyftrek 05

PRINCIPAL DISPLAY PANEL - 10 mg/50 mg/125 mg Blister Pack Carton - alyftrek 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.